Product Overview
Rimonabant | T1519L | TargetMol Chemicals
CAS: 168273-06-1
Smiles: Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1
Formula: C22H21Cl3N4O
Pathway: GPCR/G Protein|||Metabolism|||Microbiology/Virology
Target: Cannabinoid Receptor|||Antibacterial|||Acyltransferase
Receptor: N/A
Bioactivity: Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States.
Molecular Weight: 463, 79
